You may not notice it until after puberty, when you start having more regular erections
27S31 N
Laboratory investigations have revealed FOXO4-DRI's exceptional selectivity for senescent cells, with research demonstrating that more than 80% of senescent cells undergo apoptosis while healthy cells remain unaffected
Availability of data and materials All data generated or analysed during this study are included in this published article
- Most evidence comes from animal studies - Human data is extremely limited - No FDA approval for orthopedic use - Clinical benefit in musculoskeletal conditions remains unproven While the biology is interesting, potential does not equal proven clinical outcomes
In some embodiments, the formulations or compositions described herein have a pH and osmolarity as described herein, and have a concentration of active pharmaceutical ingredient between about 0.01-about 20%, between about 0.01-about 10%, between about 0.01-about 7%, between about 0.01-5%, between about 0.01-about 3%, between about 0.01-about 2% of the active ingredient by weight of the formulation or composition
